NCT06219174 2026-03-06Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO)H. Lee Moffitt Cancer Center and Research InstitutePhase 1/2 Suspended45 enrolled